Medicines Company (MDCO) Stock Quote

Detailed Quote for Medicines Company (MDCO)

After Hours: $ 20.75

0.00 (0.00%)

Volume: 345

4:50 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 7, 2012

Close: 22.48

52 Week Low

August 9, 2011

Close: 12.33

Today

Last Price
20.75

Change $
0.24

Change %
1.14%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
21.02

High
21.02

Low
20.65

Prev Close
20.99

Last Trade
4:00

Volume
613.4 k

52 Wk Hi
22.48

52 Wk Low
12.33

Market Cap
1.12 b

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
54,200,472

EPS (TTM)
3.10

PE Ratio
6.80

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Medicines Company (MDCO)

Sector News | Topic News

News for MDCO

Fri, Feb 03, 2012

4:15 PM

The Medicines Company to Announce Fourth Quarter and Full Year 2011 Financial Results on Wednesday, February 22, 2012 - Marketwire

Mon, Jan 23, 2012

7:30 AM

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With App Pharmaceuticals - Marketwire

Tue, Jan 17, 2012

4:36 PM

The Medicines Company's Cangrelor Bridge Trial Published in the Journal of the American Medical Association - Marketwire

Thu, Dec 22, 2011

4:30 PM

The Medicines Company to Participate in the 30th Annual J.P. Morgan Healthcare Conference 2012 - Marketwire

Mon, Dec 05, 2011

8:00 AM

The Medicines Company Invests Equity Stake in GeNO, LLC, Nitric Oxide Delivery and Technology Company - Marketwire

Wed, Nov 30, 2011

4:30 PM

The Medicines Company to Participate in the 2011 Deutsche Bank BioFEST - Marketwire

Mon, Nov 14, 2011

4:31 PM

The Medicines Company's MDCO-216 (ApoA-I Milano Complex) Demonstrates Capacity to Clear Cholesterol From Cells in Preclinical Model - Marketwire

Sun, Nov 13, 2011

12:48 PM

German Researchers Reaffirm Utility of Angiomax(R)/Angiox(R) (Bivalirudin) in High Risk PCI Patients - Marketwire

Wed, Nov 09, 2011

3:50 PM

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT - Marketwire

Tue, Nov 08, 2011

3:42 PM

First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT - Marketwire

Wed, Nov 02, 2011

4:30 PM

The Medicines Company Announces Schedule of Events at Upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference - Marketwire

Fri, Oct 28, 2011

9:00 AM

For Immediate Release to US Investors: The Medicines Company and Daiichi Sankyo Announce Angiox(R) (Bivalirudin) Co-Promotion for Germany - Marketwire

Wed, Oct 26, 2011

8:02 AM

The Medicines Company Reports Third Quarter 2011 Results - Marketwire

Sat, Oct 15, 2011

1:00 PM

The Medicines Company's MDCO-2010 Meets Clinical Trial Objectives in Patients Undergoing Open-Heart Surgery - Marketwire

Wed, Oct 12, 2011

4:30 PM

The Medicines Company to Announce Third Quarter 2011 Financial Results on Wednesday, October 26, 2011 - Marketwire

Mon, Oct 03, 2011

11:00 AM

The Medicines Company Launches New Formulation of Cleviprex(R) (Clevidipine) Injectable Emulsion - Marketwire

6:30 AM

The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With Teva - Marketwire

Thu, Sep 22, 2011

4:30 PM

The Medicines Company to Participate in the Jefferies 2011 Global Healthcare Conference in London - Marketwire

Wed, Sep 14, 2011

4:30 PM

The Medicines Company to Participate in the UBS Global Life Sciences Conference - Marketwire

Mon, Sep 12, 2011

8:00 AM

The Medicines Company Launches 50mL Ready-to-Use Formulation of Argatroban Injection - Marketwire

More News for MDCO >>

Tags for Medicines Company

Research stocks or mutual funds related to Medicines Company by keywords or tags. Find companies that have a similar focus to MDCO. The keywords below have been associated to MDCO by either user submission or electronic means.

schering plough health care products biotech research pharmaceuticals research pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceutical investment financial annual report pharmaceutical research and development annual report pharmaceutical manufacturing company dupont pharmaceuticals pharma manufacturing company earnings pharma license novartis pharmaceuticals generic products pharmaceutical cro pharma consulting active pharmaceutical ingredients health care marketing pharmaceutical sales pharma consultants pharmaceutical distributors mckesson products biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical magazine biotech pharmaceutical pr Drugs annual report of company massengill products corporate annual report pharma r&d pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical translations pharmaceutical formulation electronic medicines compendium pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical events